Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02162680Phase 4Completed
A Phase 4 trial of lidocaine, bacteriostatic sodium chloride 0.9% injection in procedural pain, sponsored by Duke University. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02162680.